Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

戻る Agenda

Session 6: Data Transparency: How do We Measure Up?

Session Chair(s)

Melanie North, PhD

Clinical Trial Transparency and Disclosure , Melanie North Consulting, United States

In this session we will hear from prominent commentators on the status of clinical trial data disclosure in 2017. We will start with a discussion about the reporting of outcome measures and hear the latest on the All Trials TrialsTracker and the Good Pharma Scorecard. As a late-breaking addition we will hear industry’s response and analysis of compliance with clinical trial registration and reporting requirements.

Learning Objective :
Appreciate external stakeholders’ perspectives on clinical trial transparency
Understand how compliance is being measured by these groups
Recognize the importance of consistency in outcome measure reporting between registries, publications, and source documents that are now available to the public.

Speaker(s)

Speaker

Henry Drysdale

Honorary Clinical Research Fellow, University of Oxford, United Kingdom

Speaker

April Clyburne-Sherin

AllTrials USA Campaign Manager, Sense About Science USA, United States

Speaker

Jennifer Miller, PhD

Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics, Yale School of Medicine, United States

Speaker

Olivia Shopshear, MS

Senior Director, US Regulatory Policy Lead, Biogen, United States

Q&A Panel Discussion

Panel Discussion

, All Session Speakers, United States

Clinical Trial Disclosure and Data Transparency Conference

Session 6: Data Transparency: How do We Measure Up?

Session Chair(s)

Melanie North, PhD

Speaker(s)

最新情報や機会を逃さないで